Skip To Main Content
Le contenu de ce site web est exclusivement réservé aux professionnels de santé en Belgique et au Luxembourg.
Campus
  • Aires thérapeutiques
  • Ressources
Campus
  • Aires thérapeutiques
  • Ressources
View Full Results

Articles

Sort by

Filtres

Réinitialiser
  • Aires thérapeutiques

Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities

Explorer

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

Explorer

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

Explorer

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Explorer

Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy

Explorer

Are you ready to test your knowledge about cardiac involvement in Fabry?

Explorer

IL-4 et IL-13 : au cœur des mécanismes de l’inflammation de type 2

Explorer

Understanding Gaucher Disease: Symptoms, Classification, and Clinical Presentation

Gaucher disease is a lysosomal storage disorder caused by a pathogenic variant in the gene responsible for producing the enzyme acid β-glucosidase. More than 300 alleles carrying pathogenic variants have already been identified.1

Explorer

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Explorer

Defining ITP

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5

Explorer

Living with ITP

Patients reported significant quality of life (QoL) challenges related to their ITP1

Explorer

Assessing fatigue in ITP patients

For ITP patients, several scales are available to measure and track fatigue and its impact on quality of life. These tools can help patients and healthcare providers gauge symptoms and adjust their ITP treatment accordingly.1-4

Explorer